~~<i id='EC34AFA30A'><strike id='EC34AFA30A'><tt id='EC34AFA30A'><pre id='EC34AFA30A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

knowledge

author：comprehensive 2025-09-06 03:32:52 - browse：6994

Calling Bullshit course University of Washington — Screenshot via callingbullshit.org

Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

The class website and colorful syllabus went online last month and almost instantly went viral.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： 3 questions for the future of Biden's cancer moonshot

focus

leisure time

hotspot

knowledge

leisure time

focus

AdobeIt’sbeenoneyearsincetheU.S.surgeongeneralissuedanationalwarningaboutanepidemicofloneliness.Othe

WSS

Ultragenyx gene therapy for rare liver ailment succeeds in late

Intellia reports positive results for its CRISPR

A virus, fished out of a lake, may have saved a man’s life

Cord blood banking comes at a high cost to babies

What to expect at HLTH 2023, the health care industry conference

The future of health care in the House

entertainment

knowledge

focus

As demand for Covid shots wanes, Moderna seeks its next success

Chan Zuckerberg Biohub Chicago to focus on inflammation

At least 13 dead in Texas as scorching temps continue

Bristol 'take

23andMe had bad news about my health. I wish a person had delivered it

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Affirmative action in medical school literally saved lives

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Affirmative action in medical school literally saved lives

3 questions for the future of Biden's cancer moonshot

leisure time

HIV drugs protect against transmission, even in unprotected sex

Senate panel eyes new effort on drug shortages

How to increase colonoscopy rates? Looks like an AI can help

FDA's Pazdur wants cancer trials to range beyond China alone

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

VC firm General Catalyst wants to buy a health system

hotspot

knowledge

leisure time

focus